Cargando…

Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV

BACKGROUND: Low thyroxine (T4) levels have been observed in critically ill patients; however, controversial results regarding T4 supplemental therapy are reported. The association between serum free T4 (FT4) levels and mortality in critically ill patients has not been fully established and needs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Juan-Juan, Du, Ding-Fu, Ma, Gang, Jiang, Ming-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248474/
https://www.ncbi.nlm.nih.gov/pubmed/37305055
http://dx.doi.org/10.3389/fendo.2023.1164369
_version_ 1785055382890086400
author Dai, Juan-Juan
Du, Ding-Fu
Ma, Gang
Jiang, Ming-Jie
author_facet Dai, Juan-Juan
Du, Ding-Fu
Ma, Gang
Jiang, Ming-Jie
author_sort Dai, Juan-Juan
collection PubMed
description BACKGROUND: Low thyroxine (T4) levels have been observed in critically ill patients; however, controversial results regarding T4 supplemental therapy are reported. The association between serum free T4 (FT4) levels and mortality in critically ill patients has not been fully established and needs to be clarified. METHODS: Data from the Medical Information Mart for Intensive Care (MIMIC)-IV were collected and analyzed. The association between FT4 level and 30-day mortality after ICU admission was analyzed using Kaplan–Meier curves, spline smoothing fitting, martingale residuals of the null Cox model, and restricted cubic spline (RCS). Logistic regression, Cox regression, and receiver operating characteristic curve (ROC) were used to uncover the relationship and predictive value of serum FT4 and 30-day mortality in critically ill patients. RESULTS: In the final analysis, 888 patients were enrolled, and the serum FT4 levels were divided into four groups. A significant difference in 30-day mortality was observed between the four groups. Kaplan–Meier curves also presented significantly higher 30-day mortality in groups 1 and 2 (p < 0.0001). Further multivariance logistic regression showed that group 1 with FT4 levels lower than 0.7 μg/dl can predict 30-day mortality (odds ratio (OR) = 3.30, 95% confidence interval (CI) = 1.04–11.31). Spline smoothing fitting analysis showed a “V”-shaped line between 30-day mortality and FT4 level within 0–3 μg/dl. Further RCS analysis showed that the risk of death decreased rapidly as FT4 levels increased when serum FT4 levels were lower than 1.2 μg/dl and started to become flat afterward. The area under the ROC of the lower FT4 level to predict 30-day mortality was 0.833 (95% CI = 0.788–0.878). Both multivariant Cox regression and logistic regression showed that FT4 levels lower than 1.2 μg/dl can independently predict 30-day mortality when adjusted for other potential confounders (HR = 0.34, 95% CI = 0.14–0.82; OR = 0.21, 95% CI = 0.06–0.79, respectively), but its predictive power disappeared when adjusted for T3 or total T4. CONCLUSION: Serum FT4 levels were significantly negatively associated with 30-day mortality when they were lower than 1.2 μg/dl and could predict the risk of 30-day mortality. A higher FT4 level is potentially related to increased 30-day mortality.
format Online
Article
Text
id pubmed-10248474
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102484742023-06-09 Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV Dai, Juan-Juan Du, Ding-Fu Ma, Gang Jiang, Ming-Jie Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Low thyroxine (T4) levels have been observed in critically ill patients; however, controversial results regarding T4 supplemental therapy are reported. The association between serum free T4 (FT4) levels and mortality in critically ill patients has not been fully established and needs to be clarified. METHODS: Data from the Medical Information Mart for Intensive Care (MIMIC)-IV were collected and analyzed. The association between FT4 level and 30-day mortality after ICU admission was analyzed using Kaplan–Meier curves, spline smoothing fitting, martingale residuals of the null Cox model, and restricted cubic spline (RCS). Logistic regression, Cox regression, and receiver operating characteristic curve (ROC) were used to uncover the relationship and predictive value of serum FT4 and 30-day mortality in critically ill patients. RESULTS: In the final analysis, 888 patients were enrolled, and the serum FT4 levels were divided into four groups. A significant difference in 30-day mortality was observed between the four groups. Kaplan–Meier curves also presented significantly higher 30-day mortality in groups 1 and 2 (p < 0.0001). Further multivariance logistic regression showed that group 1 with FT4 levels lower than 0.7 μg/dl can predict 30-day mortality (odds ratio (OR) = 3.30, 95% confidence interval (CI) = 1.04–11.31). Spline smoothing fitting analysis showed a “V”-shaped line between 30-day mortality and FT4 level within 0–3 μg/dl. Further RCS analysis showed that the risk of death decreased rapidly as FT4 levels increased when serum FT4 levels were lower than 1.2 μg/dl and started to become flat afterward. The area under the ROC of the lower FT4 level to predict 30-day mortality was 0.833 (95% CI = 0.788–0.878). Both multivariant Cox regression and logistic regression showed that FT4 levels lower than 1.2 μg/dl can independently predict 30-day mortality when adjusted for other potential confounders (HR = 0.34, 95% CI = 0.14–0.82; OR = 0.21, 95% CI = 0.06–0.79, respectively), but its predictive power disappeared when adjusted for T3 or total T4. CONCLUSION: Serum FT4 levels were significantly negatively associated with 30-day mortality when they were lower than 1.2 μg/dl and could predict the risk of 30-day mortality. A higher FT4 level is potentially related to increased 30-day mortality. Frontiers Media S.A. 2023-05-25 /pmc/articles/PMC10248474/ /pubmed/37305055 http://dx.doi.org/10.3389/fendo.2023.1164369 Text en Copyright © 2023 Dai, Du, Ma and Jiang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Dai, Juan-Juan
Du, Ding-Fu
Ma, Gang
Jiang, Ming-Jie
Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title_full Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title_fullStr Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title_full_unstemmed Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title_short Association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from MIMIC-IV
title_sort association between serum-free thyroxine level and all-cause mortality in critically ill patients: a retrospective study from mimic-iv
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248474/
https://www.ncbi.nlm.nih.gov/pubmed/37305055
http://dx.doi.org/10.3389/fendo.2023.1164369
work_keys_str_mv AT daijuanjuan associationbetweenserumfreethyroxinelevelandallcausemortalityincriticallyillpatientsaretrospectivestudyfrommimiciv
AT dudingfu associationbetweenserumfreethyroxinelevelandallcausemortalityincriticallyillpatientsaretrospectivestudyfrommimiciv
AT magang associationbetweenserumfreethyroxinelevelandallcausemortalityincriticallyillpatientsaretrospectivestudyfrommimiciv
AT jiangmingjie associationbetweenserumfreethyroxinelevelandallcausemortalityincriticallyillpatientsaretrospectivestudyfrommimiciv